Zdrowie i gospodarka · 06/05/2008

FDA Requests Public Comment on Proposed Collection of Information for Fast Track Drug Development Programs

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to fast track drug development programs, which are designed to expedite the review process for new drugs and biologics.